These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 24375193)

  • 1. Associations between polymorphisms of the XPC gene and lung cancer susceptibility: a meta-analysis.
    Zhu ML; Hua RX; Zheng L
    Tumour Biol; 2014 Apr; 35(4):2931-9. PubMed ID: 24375193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Associations of Lys939Gln and Ala499Val polymorphisms of the XPC gene with cancer susceptibility: a meta-analysis.
    He J; Shi TY; Zhu ML; Wang MY; Li QX; Wei QY
    Int J Cancer; 2013 Oct; 133(8):1765-75. PubMed ID: 23400628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. XPC Lys939Gln and Ala499Val polymorphisms in colorectal cancer susceptibility: a meta-analysis of case-control studies.
    Liu C; Yin Q; Ying M; Lin J; Li L; Jiao G; Wang M; Wang Y
    Mol Biol Rep; 2014 Feb; 41(2):1171-8. PubMed ID: 24385304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of XPC Polymorphisms with Cutaneous Malignant Melanoma Risk: Evidence from a Meta-Analysis.
    Asadian F; Niktabar SM; Ghelmani Y; Kargar S; Akbarian E; Emarati SA; Sadeghizadeh-Yazdi J; Neamatzadeh H
    Acta Medica (Hradec Kralove); 2020; 63(3):101-112. PubMed ID: 33002396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of DNA repair gene XPC Ala499Val (rs2228000 C>T) and Lys939Gln (rs2228001 A>C) polymorphisms with the risk of chronic myeloid leukemia: A case-control study in a South Indian population.
    Lakkireddy S; Aula S; Kapley A; Gundeti S; Kutala VK; Jamil K
    J Gene Med; 2021 Jul; 23(7):e3339. PubMed ID: 33829606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. XPC gene polymorphisms contribute to bladder cancer susceptibility: a meta-analysis.
    Dai QS; Hua RX; Zeng RF; Long JT; Peng ZW
    Tumour Biol; 2014 Jan; 35(1):447-53. PubMed ID: 23918308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Correlation of XPC Ala499Val and Lys939Gln polymorphisms to risks of esophageal squamous cell carcinoma and gastric cardiac adenocarcinoma].
    Zhou RM; Li Y; Wang N; Zhang XJ; Dong XJ; Guo W
    Ai Zheng; 2006 Sep; 25(9):1113-9. PubMed ID: 16965652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of XPC polymorphisms and lung cancer risk: a meta-analysis.
    Jin B; Dong Y; Zhang X; Wang H; Han B
    PLoS One; 2014; 9(4):e93937. PubMed ID: 24736739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of XPC polymorphisms with susceptibility and clinical outcome to chemotherapy in breast cancer patients.
    Yang X; Liu D; Wu H; Kang H; Pang H; Huang D; Sha X; Wang E; Wang Z; Wei M
    Cancer Sci; 2012 Jul; 103(7):1207-14. PubMed ID: 22519360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A meta-analysis of evidences on XPC polymorphisms and lung cancer susceptibility.
    Liu C; Yin Q; Hu J; Li L; Zhang Y; Wang Y
    Tumour Biol; 2013 Apr; 34(2):1205-13. PubMed ID: 23381646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Association of XPC gene polymorphisms with breast cancer risk].
    Wu YY; Ma XY; Yao KY; Li QL; Chen K
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2011 May; 40(3):252-8. PubMed ID: 21671483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymorphisms in the XPC gene affect urinary bladder cancer risk: a case-control study, meta-analyses and trial sequential analyses.
    Sankhwar M; Sankhwar SN; Bansal SK; Gupta G; Rajender S
    Sci Rep; 2016 Jun; 6():27018. PubMed ID: 27246180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current evidences on XPC polymorphisms and breast cancer susceptibility: a meta-analysis.
    Zheng W; Cong XF; Cai WH; Yang S; Mao C; Zou HW
    Breast Cancer Res Treat; 2011 Aug; 128(3):811-5. PubMed ID: 21318603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymorphisms of the XPC gene may contribute to the risk of head and neck cancer: a meta-analysis.
    Zhang Y; Li Z; Zhong Q; Zhou W; Chen X; Chen X; Fang J; Huang Z
    Tumour Biol; 2014 Apr; 35(4):3917-31. PubMed ID: 24338715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An association between XPC Lys939Gln polymorphism and the risk of bladder cancer: a meta-analysis.
    Zhang Y; Wang X; Zhang W; Gong S
    Tumour Biol; 2013 Apr; 34(2):973-82. PubMed ID: 23269608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. XPC Lys939Gln polymorphism is associated with the decreased response to platinum based chemotherapy in advanced non-small-cell lung cancer.
    Zhu XL; Sun XC; Chen BA; Sun N; Cheng HY; Li F; Zhang HM; Feng JF; Qin SK; Cheng L; Lu ZH
    Chin Med J (Engl); 2010 Dec; 123(23):3427-32. PubMed ID: 22166526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current evidences on XPC polymorphisms and gastric cancer susceptibility: a meta-analysis.
    Peng Q; Chen Z; Lu Y; Lao X; Mo C; Li R; Qin X; Li S
    Diagn Pathol; 2014 May; 9():96. PubMed ID: 24886180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. XPC Lys939Gln polymorphism contributes to colorectal cancer susceptibility: evidence from a meta-analysis.
    Peng Q; Lao X; Tang W; Chen Z; Li R; Qin X; Li S
    Diagn Pathol; 2014 Jun; 9():120. PubMed ID: 24947936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The association between XPC Lys939Gln gene polymorphism and urinary bladder cancer susceptibility: a systematic review and meta-analysis.
    Dou K; Xu Q; Han X
    Diagn Pathol; 2013 Jul; 8():112. PubMed ID: 23819639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA repair genes polymorphism and lung cancer risk with the emphasis to sex differences.
    Letkova L; Matakova T; Musak L; Sarlinova M; Krutakova M; Slovakova P; Kavcova E; Jakusova V; Janickova M; Drgova A; Berzinec P; Halasova E
    Mol Biol Rep; 2013 Sep; 40(9):5261-73. PubMed ID: 23673479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.